Evaluation of toceranib for treatment of apocrine gland anal sac adenocarcinoma in dogs.
Caitlin M HeatonArthur F A FernandesPaulo C JarkXuan PanPublished in: Journal of veterinary internal medicine (2020)
Toceranib is effective in the treatment of AGASACA in dogs. Prospective, controlled clinical trials are needed to determine the efficacy of toceranib in comparison to other treatment protocols for dogs with AGASACA.